Empowering the FDA with AI: The Future of Regulatory Efficiency
In a bold move toward modernization, the FDA is embracing artificial intelligence (AI) to revolutionize its regulatory operations. By June 2025, AI-integrated scientific reviews are expected to set new benchmarks for efficiency in public health protection. This transition foregrounds AI's potential to significantly condense review times and enhance